NMPA/PMDA News
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Navigate NMPA & PMDA drug approvals, regulatory updates, and market access strategies. Stay ahead in China & Japan pharma with critical intelligence.
Showing 1–12 of 15 articles
Quick answer
NovaPharmaNews NMPA/PMDA News hub for NMPA covers 15 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
PMDA Regulatory Updates: New Orphan Drug Portal and ASEAN Symposium Open
PMDA Approves New Pharmaceuticals and Medical Devices: What's New
Rusan Pharma Secures PMDA GMP Approval, Boosting Global Market Access
GlycoNex Secures PMDA Approval for GNX1021 Phase I Trial
Rusan Pharma Achieves Global GMP Milestone with PMDA Approval
Roche's Alecensa Expansion: Implications for Pharma Stakeholders
Rusan Pharma Secures GMP Clearance from Japan's PMDA
China Clinical Trial Regulations: Key Insights on NMPA Reforms 2024
Radioligand Therapies for Prostate Cancer: Market Access and Clinical Insights in APAC
NMPA Priority Review Pathway: What You Need to Know About Innovative Drug Approvals
PMDA approves AI-driven platform: What You Need to Know
PMDA SAKIGAKE Designation: Accelerating Regenerative Medicine Market Access in Japan
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.